Intervention not reported
Mortality (all‐cause) ‐ formoterol versus salbutamol ( · patients with chronic asthma
The intervention showed no clear difference in mortality (all‐cause) ‐ formoterol versus salbutamol ( (moderate certainty).
1 finding from 1 review
- Regular treatment with formoterol for chronic asthma: serious adverse events 2012 · Cochrane Headline outcomes onlyOR 0.5 [0.03, 8.05]6 studies · 1418 participantsModerate